1
|
Zhang P, Yan SJ, Hu J, Liu HP, Xia W, Yang M, Kuang QH, Shi KL, Fu MZ, Gao CL, Xia ZK. Clinical outcomes and clinico-pathological correlations in children with MPO-ANCA-associated glomerulonephritis showing renal arteritis. J Investig Med 2024; 72:511-521. [PMID: 38594222 DOI: 10.1177/10815589241248073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/11/2024]
Abstract
The aim of this study was to evaluate the clinical features, pathological characteristics, and prognosis in myeloperoxidase (MPO)-antineutrophil cytoplasmic antibodies (ANCA)-associated glomerulonephritis (AAGN) with renal arteritis. The study involved 97 children from five pediatric clinical centers with MPO-AAGN who exhibited distinct clinical features. The patients were divided into AAGN-A+ and AAGN-A-, based on the presence or absence of arteritis, and the disparities in clinical, histopathological characteristics, and prognosis between the two groups was evaluated. In contrast to the AAGN-A- group, the children in the AAGN-A+ group exhibited more pronounced clinical symptoms and renal pathological injury. Arteritis positively moderately correlated with the serum creatinine, interleukin-6, urinary neutrophil gelatinase-associated lipocalin, negatively moderately correlated with serum complement C3. The renal survival rate in the AAGN-A+ group was significantly poorer than AAGN-A- group (χ2 = 4.278, p = 0.039). Arteritis showed a good predictive value for end-stage kidney disease (ESKD), and C3 deposition, ANCA renal risk score and arteritis were independent risk factors for the development of ESKD in children with MPO-AAGN. Arteritis is a significant pathological change observed in children with MPO-AAGN, and the formation of arteritis may be related to the inflammatory response and activation of the complement system.
Collapse
Affiliation(s)
- Pei Zhang
- Department of Pediatrics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
| | - Shi-Jun Yan
- Department of Pediatrics, Qinhuai Medical District, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
| | - Jian Hu
- Department of Pediatrics, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, China
| | - Hai-Peng Liu
- Department of Emergency, Xuzhou Children's Hospital, Affiliated to Xuzhou Medical University, Xuzhou, China
| | - Wei Xia
- Department of Pediatric Nephrology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China
| | - Meng Yang
- Institute of Literature in Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China
| | - Qian-Huining Kuang
- Department of Pediatrics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
| | - Kai-Li Shi
- Department of Pediatrics, Jinling Hospital, Nanjing Medical University, Nanjing, China
| | - Meng-Zhen Fu
- Department of Pediatrics, Jinling Hospital, Nanjing Medical University, Nanjing, China
| | - Chun-Lin Gao
- Department of Pediatrics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
| | - Zheng-Kun Xia
- Department of Pediatrics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
| |
Collapse
|
2
|
Banerjee S, Rose E, Panicker S, Dugan J, Khalidi N, Koening CL, Langford CA, Monach PA, Pagnoux C, McAlear CA, Merkel PA. Signal Regulatory Protein α Expression in Systemic Vasculitis. ACR Open Rheumatol 2024. [PMID: 39010674 DOI: 10.1002/acr2.11716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2024] [Revised: 06/03/2024] [Accepted: 06/10/2024] [Indexed: 07/17/2024] Open
Abstract
OBJECTIVE Signal regulatory protein α (SIRPα) is found primarily on myeloid cells, including macrophages and neutrophils; binds to CD47; and regulates phagocytosis, antigen presentation, cellular fusion, cell proliferation, and migration. Therefore, SIRPα may be involved in the pathogenesis of autoimmune diseases, including systemic vasculitis. This study aimed to assess SIRPα expression in tissue samples from patients with vasculitis. METHODS Immunohistochemical staining for SIRPα was performed on temporal artery (TA), kidney, and lung biopsy samples from patients with giant cell arteritis (GCA), patients with microscopic polyangiitis (MPA), patients with granulomatosis with polyangiitis (GPA), and patients without vasculitis. A score of SIRPα+ expression was calculated, derived from the percentages of monocytes, macrophages, and dendritic cells and neutrophils with different staining intensities in affected tissues. RESULTS A total of 46 samples from patients with different vasculitides (GCA, MPA, and GPA) were included in the study. Tissue samples included TA samples from 15 patients with GCA; kidney samples from 11 and 9 patients with GPA and MPA, respectively; and lung samples from 11 patients with GPA. Most tissue samples from patients with active vasculitis (15 of 15 TA samples, 17 of 20 kidney samples, and 9 of 11 lung samples) showed SIRPα staining. SIRPα staining intensity was less in kidney samples compared to TA and lung samples. CONCLUSION This study demonstrates high-level expression of SIRPα in macrophages and monocytes in affected tissue in systemic vasculitis. These findings provide a foundation for further studies exploring the role of the SIRPα-CD47 pathway in the pathogenesis of systemic vasculitis and the potential for the blockade of SIRPα and/or the depletion of SIRPα+ cells as treatment of systemic vasculitis.
Collapse
Affiliation(s)
| | - Eileen Rose
- Electra Therapeutics, Inc, South San Francisco, California
| | | | | | - Nader Khalidi
- McMaster University and St. Joseph's Hospital, Hamilton, Ontario, Canada
| | | | | | | | - Christian Pagnoux
- University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada
| | | | | |
Collapse
|
3
|
Vainutienė V, Ivaška J, Dadonienė J, Beleškienė V, Ivaškienė T, Lesinskas E. Audiological Manifestations in Patients with Granulomatosis with Polyangiitis. MEDICINA (KAUNAS, LITHUANIA) 2024; 60:267. [PMID: 38399554 PMCID: PMC10890050 DOI: 10.3390/medicina60020267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/23/2023] [Revised: 01/30/2024] [Accepted: 02/01/2024] [Indexed: 02/25/2024]
Abstract
Background and Objectives: Granulomatosis with Polyangiitis (GPA) is a rare, autoimmune, multisystemic disease characterized by vasculitis and necrotizing granuloma that commonly affects the upper and lower respiratory tract and kidneys. Audiovestibular dysfunction in GPA diseases may have different clinical presentations. The aim of the present study was to evaluate hearing function in patients with GPA and to compare the results with a healthy control group. Materials and Methods: A total of 34 individuals participated in the study. The GPA group consisted of 14 participants, and the control group was composed of 20 healthy participants with no signs or symptoms of ear disease. The ages ranged from 18 to 65 years old, with a mean age of 43.8 years. The participants underwent a complete audiological evaluation using otoscopy, impedance audiometry, pure tone audiometry, speech audiometry-evaluation of speech thresholds, and speech recognition in quiet. Both ears were tested. All of the participants of the study were native Lithuanian speakers. Data were statistically analyzed using the Statistical Analysis System software SAS® Studio 3.8. A p value < 0.05 was regarded as statistically significant. Results: 92.85% of patients from the GPA group reported hearing-related symptoms: hearing loss, tinnitus, and fullness in the ears. The arithmetic means of all hearing thresholds at frequencies from 125 Hz to 8000 Hz were significantly higher in the GPA group. The results revealed statistically significant differences between the two groups in the Speech Detection Threshold, Speech Recognition Threshold, Speech Discomfort level, and Word Recognition Scores. Conclusions: The frequency of hearing loss, the average hearing thresholds, and speech thresholds were higher in GPA patients than in healthy individuals. The most common type of hearing loss was sensorineural. Audiological assessments should be considered during the routine evaluation of patients with GPA disease to prevent hearing-related disabilities.
Collapse
Affiliation(s)
- Vija Vainutienė
- State Research Institute Centre for Innovative Medicine, Santariškių str. 5, LT-08406 Vilnius, Lithuania; (J.D.); (T.I.)
| | - Justinas Ivaška
- Clinic of Ear, Nose, Throat and Eye Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M.K. Čiurlionio str. 21, LT-03101 Vilnius, Lithuania; (J.I.); (V.B.); (E.L.)
| | - Jolanta Dadonienė
- State Research Institute Centre for Innovative Medicine, Santariškių str. 5, LT-08406 Vilnius, Lithuania; (J.D.); (T.I.)
- Department of Public Health, Faculty of Medicine, Vilnius University, M.K. Čiurlionio str. 21, LT-03101 Vilnius, Lithuania
| | - Vilma Beleškienė
- Clinic of Ear, Nose, Throat and Eye Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M.K. Čiurlionio str. 21, LT-03101 Vilnius, Lithuania; (J.I.); (V.B.); (E.L.)
| | - Tatjana Ivaškienė
- State Research Institute Centre for Innovative Medicine, Santariškių str. 5, LT-08406 Vilnius, Lithuania; (J.D.); (T.I.)
| | - Eugenijus Lesinskas
- Clinic of Ear, Nose, Throat and Eye Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M.K. Čiurlionio str. 21, LT-03101 Vilnius, Lithuania; (J.I.); (V.B.); (E.L.)
| |
Collapse
|
4
|
Tampe D, Korsten P, Ströbel P, Hakroush S, Tampe B. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis. Front Immunol 2021; 12:736638. [PMID: 34630417 PMCID: PMC8495213 DOI: 10.3389/fimmu.2021.736638] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2021] [Accepted: 09/07/2021] [Indexed: 12/02/2022] Open
Abstract
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a small vessel vasculitis affecting multiple organ systems, including the kidney. Besides investigations focusing on renal outcomes, sex differences associated with distinct clinical and histopathological findings in ANCA glomerulonephritis (GN) have not been systematically investigated. Therefore, we here aimed to systematically analyze sex differences in patients with AAV and biopsy-proven ANCA GN. We provide a comprehensive analysis of 53 kidney biopsies with ANCA GN retrospectively included between 2015 and 2020 and identified specific sex differences in ANCA GN concerning laboratory parameters and systematic scoring of renal histopathology glomerular and tubulointerstitial lesions, and extrarenal manifestations of AAV. We did not observe any correlation between sex and short-term clinical AAV course or disease severity by comparing general AAV parameters. AAV manifestations in females occurred at an older age with more joint involvement. Regarding histopathological findings, we, again, observed no sex difference among ANCA GN classification, but a significant correlation between females and distinct histopathological findings with less tubulointerstitial inflammation and vasculitis of peritubular capillaries. Finally, we here identified fewer associations between clusters of clinical, laboratory parameters, and histopathological findings in females as compared to males. These findings are of great relevance and further improve our understanding of sex differences in the pathogenesis of ANCA GN. While future studies about specific sex differences and conclusions in these clusters are crucial, our observations further support that sex differences are relevant, affect distinct parameters, and influence clinical, laboratory parameters, and histopathological findings in AAV, particularly ANCA GN.
Collapse
Affiliation(s)
- Désirée Tampe
- Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany
| | - Peter Korsten
- Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany
| | - Philipp Ströbel
- Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany
| | - Samy Hakroush
- Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany
| | - Björn Tampe
- Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany
| |
Collapse
|
5
|
Selvarajah S, Ran S, Roberts NW, Nair M. Leptospirosis in pregnancy: A systematic review. PLoS Negl Trop Dis 2021; 15:e0009747. [PMID: 34520461 PMCID: PMC8462732 DOI: 10.1371/journal.pntd.0009747] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Revised: 09/24/2021] [Accepted: 08/20/2021] [Indexed: 12/29/2022] Open
Abstract
Introduction Leptospirosis is a leading zoonotic disease worldwide with more than 1 million cases in the general population per year. With leptospirosis being an emerging infectious disease and as the world’s environment changes with more floods and environmental disasters, the burden of leptospirosis is expected to increase. The objectives of the systematic review were to explore how leptospirosis affects pregnancy, its burden in this population, its effects on maternal and fetal outcomes and the evidence base surrounding treatment options. Methods We performed a systematic review of published and unpublished literature using automated and manual methods to screen nine electronic databases since inception, with no language restriction. Two reviewers independently screened articles, completed the data extraction and assessment of risk of bias. Due to significant heterogeneity and paucity of data, we were unable to carry out a meta-analysis, but we conducted a pooled analysis of individual patient data from the case reports and case series to examine the patient and disease characteristics, diagnostic methods, differential diagnoses, antibiotic treatments, and outcomes of leptospirosis in pregnancy. The protocol for this review was registered on the International Prospective Register of Systematic Reviews, PROSPERO: CRD42020151501. Results We identified 419 records, of which we included eight observational studies, 21 case reports, three case series and identified four relevant ongoing studies. Overall the studies were with moderate bias and of ‘fair’ quality. We estimated the incidence of leptospirosis in pregnancy to be 1.3 per 10,000 in women presenting with fever or with jaundice, but this is likely to be higher in endemic areas. Adverse fetal outcomes were found to be more common in pregnant patients who presented in the second trimester compared with patients who presented in the third trimester. There is overlap between how leptospirosis presents in pregnancy and in the general population. There is also overlap between the signs, symptoms and biochemical disturbances associated with leptospirosis in pregnancy and the presentation of pregnancy associated conditions, such as Pre-Eclampsia (PET), Acute Fatty Liver of Pregnancy (AFLP) and HELLP Syndrome (Haemolysis Elevated Liver enzymes Low Platelets). In 94% of identified cases with available data, there was an indicator in the patient history regarding exposure that could have helped include leptospirosis in the clinician’s differential diagnosis. We also identified a range of suitable antibiotic therapies for treating leptospirosis in pregnancy, most commonly used were penicillins. Conclusion This is the first systematic review of leptospirosis in pregnancy and it clearly shows the need to improve early diagnosis and treatment by asking early, treating early, and reporting well. Ask early—broaden differential diagnoses and ask early for potential leptospirosis exposures and risk factors. Treat early—increase index of suspicion in pregnant patients with fever in endemic areas and combine with rapid field diagnosis and early treatment. Report well—need for more good quality epidemiological studies on leptospirosis in pregnancy and better quality reporting of cases in literature. There are more than 1 million cases of leptospirosis in the general population each year. Leptospirosis is an emerging infectious disease and as the world’s environment changes with more floods and environmental disasters, the impact of leptospirosis on the world is expected to increase. Leptospirosis is a zoonotic disease passed onto humans and can cause a range of illness from mild symptoms to severe organ failure and death. It is typically underreported and understudied, hence its classification as a ‘Neglected Tropical Disease’. This is the first systematic review on Leptospirosis in Pregnancy looking at how common it is in pregnancy, how it affects maternal and fetal outcomes, and options for management. We found there to be overlap between how leptospirosis presents in the general population and in pregnancy, and that it can mimic non-infectious conditions that only present in pregnancy such as Pre-Eclampsia, Acute Fatty Liver of Pregnancy and other syndromes where liver and platelet function is affected. Adverse fetal outcomes were found to be more common in pregnant patients who presented in the second trimester compared with patients who presented in the third trimester. In 94% of identified cases with available data, there was a clue in the patient’s history that could have indicated possible exposure to leptospirosis, which is very important in raising suspicion of a diagnosis of leptospirosis in pregnancy. We also identified a range of suitable antibiotic therapies for treating leptospirosis in pregnancy, most commonly used were penicillins. Our recommendations are: Ask early—broaden differential diagnoses and ask early for potential leptospirosis exposures and risk factors. Treat early—combine considering leptospirosis as a cause of fever in pregnant patients in endemic areas with prompt diagnosis and treatment. Report well—there is a need for more good quality epidemiological studies on leptospirosis in pregnancy and better quality reporting of cases in literature.
Collapse
Affiliation(s)
- Sujitha Selvarajah
- National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, United Kingdom
- * E-mail:
| | - Shaolu Ran
- King’s College Hospital NHS Foundation Trust, London, United Kingdom
| | - Nia Wyn Roberts
- Bodleian Health Care Libraries, University of Oxford, Oxford, United Kingdom
| | - Manisha Nair
- National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, United Kingdom
| |
Collapse
|
6
|
Boudhabhay I, Delestre F, Coutance G, Gnemmi V, Quemeneur T, Vandenbussche C, Lazareth H, Canaud G, Tricot L, Gosset C, Hummel A, Terrier B, Rabant M, van Daalen EE, Wester Trejo MA, Bajema IM, Karras A, Duong Van Huyen JP. Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome. J Am Soc Nephrol 2021; 32:2362-2374. [PMID: 34155059 PMCID: PMC8729836 DOI: 10.1681/asn.2020071074] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2020] [Accepted: 05/08/2021] [Indexed: 02/04/2023] Open
Abstract
BACKGROUND Renal involvement in ANCA-associated vasculitis (AAV) is associated with poor outcomes. The clinical significance of arteritis of the small kidney arteries has not been evaluated in detail. METHODS In a multicenter cohort of patients with AAV and renal involvement, we sought to describe the clinicopathologic characteristics of patients with AAV who had renal arteritis at diagnosis, and to retrospectively analyze their prognostic value. RESULTS We included 251 patients diagnosed with AAV and renal involvement between 2000 and 2019, including 34 patients (13.5%) with arteritis. Patients with AAV-associated arteritis were older, and had a more pronounced inflammatory syndrome compared with patients without arteritis; they also had significantly lower renal survival (P=0.01). In multivariable analysis, the ANCA renal risk score, age at diagnosis, history of diabetes mellitus, and arteritis on index kidney biopsy were independently associated with ESKD. The addition of the arteritis status significantly improved the discrimination of the ANCA renal risk score, with a concordance index (C-index) of 0.77 for the ANCA renal risk score alone, versus a C-index of 0.80 for the ANCA renal risk score plus arteritis status (P=0.008); ESKD-free survival was significantly worse for patients with an arteritis involving small arteries who were classified as having low or moderate risk, according to the ANCA renal risk score. In two external validation cohorts, we confirmed the incidence and phenotype of this AAV subtype. CONCLUSIONS Our findings suggest AAV with renal arteritis represents a different subtype of AAV with specific clinical and histologic characteristics. The prognostic contribution of the arteritis status remains to be prospectively confirmed.
Collapse
Affiliation(s)
- Idris Boudhabhay
- Department of Pathology, Necker Hospital, Paris, France,Department of Nephrology and Transplantation, Necker Hospital, Paris, France,Paris University, Paris, France
| | - Florence Delestre
- Paris University, Paris, France,Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Paris, France
| | - Guillaume Coutance
- Paris-Sorbonne University, Paris, France,Department of Cardiac and Thoracic Surgery, Cardiology Institute, Paris, France
| | - Viviane Gnemmi
- Pathology Department, Lille University Hospital, Lille, France,JPARC-Jean-Pierre Aubert Research Center, Lille, France
| | - Thomas Quemeneur
- Nephrology and Internal Medicine Department, Hospital of Valenciennes, Valenciennes, France
| | - Cyrille Vandenbussche
- Nephrology and Internal Medicine Department, Hospital of Valenciennes, Valenciennes, France
| | - Helene Lazareth
- Renal Division, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, and Université de Paris, Paris, France
| | - Guillaume Canaud
- Department of Nephrology and Transplantation, Necker Hospital, Paris, France,Paris University, Paris, France
| | - Leila Tricot
- Department of Nephrology, Hôpital Foch, Suresnes, France
| | - Clément Gosset
- Department of Nephrology, Centre Universitaire de la Réunion, La Réunion, France
| | - Aurélie Hummel
- Department of Nephrology and Transplantation, Necker Hospital, Paris, France
| | - Benjamin Terrier
- Paris University, Paris, France,Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Paris, France
| | - Marion Rabant
- Department of Pathology, Necker Hospital, Paris, France
| | - Emma E. van Daalen
- Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
| | | | - Ingeborg M. Bajema
- Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
| | - Alexandre Karras
- Renal Division, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, and Université de Paris, Paris, France
| | | |
Collapse
|
7
|
The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis. Reumatologia 2017; 55:230-236. [PMID: 29332961 PMCID: PMC5746633 DOI: 10.5114/reum.2017.71638] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2017] [Accepted: 10/27/2017] [Indexed: 12/04/2022] Open
Abstract
Introduction Granulomatosis with polyangiitis (GPA) is a rare, ANCA-associated, systemic disease characterized by necrotizing small and medium vessel vasculitis of unknown etiology associated with granulomatous inflammation affecting the renal, pulmonary, upper airways, ocular systems and other tissues. Histological proof of the granulomatosis with polyangiitis (GPA) can be obtained by biopsy of clinically involved sites. The main purpose of this study was to examine histopathological changes in non-renal biopsies from patients with established diagnosis of GPA and evaluated the histological confirmation at diagnosis of this disease. Material and methods A retrospective analysis was performed in patients with GPA diagnosed and treated in clinics of the University Clinical Center (UCK) in Gdansk in 1988–2009. Results In the analyzed group of GPA patients the histopathological examination of biopsies taken from involved tissues (except kidney) was performed in 60% of patients. Thirty-six out of 93 biopsies (39%) were diagnosed as typical of GPA, 10 (10.7%) were suggestive and 51 (54.8%) were non-specific. Considering all biopsies, the diagnosis was confirmed in 24 patients (57% of patients in whom biopsies were taken). Epitheloid cell granulomas were present in 33 biopsies (43%), characteristic necrosis in 27 biopsies (35%), small vessel vasculitis in 18 biopsies (23%), while multinucleated giant cells were identified only in 9 biopsies (12%). Conclusions Histopathological examination of the affected tissues remains the gold standard of the diagnosis of GPA. Its usefulness increases, particularly in ANCA-negative patients, in the initial phase of the disease, or in patients with atypical clinical presentation. In many cases, it is necessary to repeat biopsy to establish the diagnosis. The role of the histopathological examination seems to be particularly important when ANCA is negative or clinical symptoms are atypical of GPA.
Collapse
|
8
|
Garov EV, Kryukov AI, Zelenkova VN, Sidorina NG, Kaloshina AS. [Atypical inflammation of the middle ear]. Vestn Otorinolaringol 2017; 82:9-15. [PMID: 28980587 DOI: 10.17116/otorino20178249-15] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The objective of the present study was to characterize the patients presenting with atypical inflammation of the middle ear and consider the currently available methods for their examination. A total of 20 patients at the age from 16 to 66 years were admitted to the Department of Ear Microsurgery during the period from 2008 and 2016 for the treatment of atypical inflammation of the middle ear. Eleven of them (18 ears) were found to have tuberculous lesions (TL) of the middle ear while the remaining 9 patients (11 ears) suffered giant cell vasculitis (GCV). All the patients underwent the general clinical and otorhinolaryngological examination, computed tomography of the temporal bones and the thoracic cavity organs, cytological, bacteriological, pathomorphological, and molecular-genetic studies including PCR diagnostics, rheumatological tests, as well as counseling by a phthisiotherapist and rheumatologist. The primary localization of TL in the middle ear was documented in 6 patients including its association with lung lesions in 5 cases. The clinical picture of the disease in 5 patients was that of smoldering exudative pathology and in 6 ones was accompanied by suppurative perforative otitis media. According to the laboratory analyses, bacteriological diagnostics proved efficient in 9% of the patients, pathomorphological and cytological diagnostics in 18% and 27.3% of the cases respectively while the effectiveness of PCR diagnostics was estimated at 55%. The diagnosis in individual patients was established within the period from 1 month to 1.5 years after they first sought medical advice in connection with complaints of the ear disease. Tuberculosis of the middle ear began to develop as exudative middle otitis that acquired the form of bilateral pathology in 4 patients. Three patients had a concomitant pulmonary disease. In 4 patuents, the diagnois of middle ear tuberculosis was established based on the presence of the specific antibodies and in 5 ones based on the results of the pathomorphological study. All the studies were carried out in duplicate. The period between the beginning of the disease and the establishment of the definitive diagnosis varied from 1 month to 1 year.
Collapse
Affiliation(s)
- E V Garov
- L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152
| | - A I Kryukov
- L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152; N.I .Pirogov Russian National Research Medical University, Moscow, Russia, 117997
| | - V N Zelenkova
- L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152
| | - N G Sidorina
- L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152
| | - A S Kaloshina
- L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152
| |
Collapse
|
9
|
Göçeroğlu A, Berden AE, Fiocco M, Floßmann O, Westman KW, Ferrario F, Gaskin G, Pusey CD, Hagen EC, Noël LH, Rasmussen N, Waldherr R, Walsh M, Bruijn JA, Jayne DRW, Bajema IM. ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse. PLoS One 2016; 11:e0165402. [PMID: 27973575 PMCID: PMC5156375 DOI: 10.1371/journal.pone.0165402] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2016] [Accepted: 10/11/2016] [Indexed: 11/21/2022] Open
Abstract
Relapse in ANCA-associated vasculitis (AAV) has been studied previously, but there are few studies on renal relapse in particular. Identifying patients at high risk of renal relapse may aid in optimizing clinical management. We investigated which clinical and histological parameters are risk factors for renal relapse in ANCA-associated glomerulonephritis (AAGN). Patients (n = 174) were newly diagnosed and had mild–moderate or severe renal involvement. Data were derived from two trials of the European Vasculitis Society: MEPEX and CYCAZAREM. The Cox regression model was used to identify parameters increasing the instantaneous risk (= rate) of renal relapse (useful for instant clinical decisions). For identifying predictors of renal relapse during follow-up, we used Fine & Gray’s regression model. Competing events were end-stage renal failure and death. The cumulative incidence of renal relapse at 5 years was 9.5% (95% CI: 4.8–14.3%). In the Cox model, sclerotic class AAGN increased the instantaneous risk of renal relapse. In Fine & Gray’s model, the absence of interstitial infiltrates at diagnosis was predictive for renal relapse. In this study we used two different models to identify possible relationships between clinical and histopathological parameters at time of diagnosis of AAV with the risk of experiencing renal relapse. Sclerotic class AAGN increased the instantaneous risk of renal relapse. This association is most likely due to the high proportion of sclerosed glomeruli reducing the compensatory capacity. The absence of interstitial infiltrates increased the risk of renal relapse which is a warning sign that patients with a relatively benign onset of disease may also be prone to renal relapse. Renal relapses occurring in patients with sclerotic class AAGN and renal relapses occurring in patients without interstitial infiltrates were mutually exclusive, which may indicate that they are essentially different.
Collapse
Affiliation(s)
- Arda Göçeroğlu
- Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
- * E-mail:
| | - Annelies E. Berden
- Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
| | - Marta Fiocco
- Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands
- Institute of Mathematics, Leiden University, Leiden, Netherlands
| | - Oliver Floßmann
- Renal Unit, Royal Berkshire Hospital, Reading, United Kingdom
| | | | | | - Gill Gaskin
- Department of Renal Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
| | - Charles D. Pusey
- Department of Renal Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
| | | | - Laure-Hélène Noël
- Department of Pathology, Necker Hospital, René Descartes University, Paris, France
| | - Niels Rasmussen
- Department of Autoimmune Serology, Statens Seruminstitut, Copenhagen, Denmark
| | - Rüdiger Waldherr
- Department of Pathology, University of Heidelberg, Heidelberg, Germany
| | - Michael Walsh
- Department of Medicine (Nephrology), St Joseph’s Hospital, McMaster University, Hamilton, Canada
- Department of Clinical Epidemiology & Biostatistics, St Joseph’s Hospital, McMaster University, Hamilton, Canada
| | - Jan A. Bruijn
- Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
| | - David R. W. Jayne
- Lupus and Vasculitis Clinic, Addenbrooke’s Hospital, Cambridge, United Kingdom
| | - Ingeborg M. Bajema
- Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
| | | |
Collapse
|
10
|
Sung IY, Kim YM, Cho YC, Son JH. Role of gingival manifestation in diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis). J Periodontal Implant Sci 2015; 45:247-51. [PMID: 26734495 PMCID: PMC4698952 DOI: 10.5051/jpis.2015.45.6.247] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2015] [Accepted: 11/27/2015] [Indexed: 11/22/2022] Open
Abstract
Purpose This report describes a case of granulomatosis with polyangiitis (GPA) in which the gingival manifestation was crucial in both making an early diagnosis and possibly in deciding the approach to treatment. Methods A 57-year-old sailor presented to the Department of Dentistry at Ulsan University Hospital complaining of gingival swelling since approximately 2 months. He had orofacial granulomatous lesions and the specific gingival manifestation of strawberry gingivitis. Results The diagnosis of GPA was made on the basis of clinical symptoms and signs, and confirmed by the presence of the anti-neutrophil cytoplasmic antibody and a positive biopsy. The patient was admitted to the hospital and subsequently placed on a disease-modifying therapy regimen that included methotrexate and prednisone. Conclusions Identification of the gingival manifestation of the disease permitted an early diagnosis and prompt therapy in a disease in which time is a crucial factor. Because of its rapid progression and potentially fatal outcome, an early diagnosis of GPA is important. Therefore, dentists should be aware of the oral signs and symptoms of such systemic diseases.
Collapse
Affiliation(s)
- Iel-Yong Sung
- Department of Dentistry, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Young-Min Kim
- Department of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Yeong-Cheol Cho
- Department of Dentistry, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Jang-Ho Son
- Department of Dentistry, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| |
Collapse
|
11
|
Endo A, Hoshino J, Suwabe T, Sumida K, Mise K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Sawa N, Takaichi K, Ohashi K, Fujii T, Ubara Y. Significance of small renal artery lesions in patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis. J Rheumatol 2014; 41:1140-6. [PMID: 24737910 DOI: 10.3899/jrheum.130657] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis is a vasculitis affecting the glomerular capillaries and small renal arteries. Although crescent formation has been reported to be characteristic of this condition, the significance of coexisting vasculitis affecting the small renal arteries has not been investigated. METHODS Fifty patients with ANCA-positive rapidly progressive glomerulonephritis whose renal biopsy specimens contained arterioles and/or interlobular arteries were retrospectively evaluated. Cellular crescents and/or necrotizing glomerulonephritis were noted in all 50 patients. Ten patients had vasculitis of the small renal arteries (group A) and 40 patients were without such vasculitis (group B). The clinical features of these 2 groups were compared. RESULTS Group A comprised 4 patients who had granulomatosis with polyangiitis (GPA) and 6 with microscopic polyangiitis (MPA), while group B included 1 patient with GPA and 39 with MPA. No patient in either group had eosinophilic granulomatosis with polyangiitis. The C-reactive protein (CRP) level was significantly higher in group A compared with group B (11.58 ± 6.19 vs 2.7 ± 3.55 mg/dl, p < 0.05), and pulmonary involvement was more frequent in group A than group B (80% vs 37.5%, p < 0.05). CONCLUSION In patients with ANCA-positive glomerulonephritis, vasculitis of small renal arteries may be associated with systemic vasculitis (including pulmonary involvement) because of elevated CRP, a systemic inflammatory marker related to overproduction of interleukin 6.
Collapse
Affiliation(s)
- Akiko Endo
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital.
| | - Junichi Hoshino
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Tatsuya Suwabe
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Keiichi Sumida
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Koki Mise
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Rikako Hiramatsu
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Eiko Hasegawa
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Masayuki Yamanouchi
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Noriko Hayami
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Naoki Sawa
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Kenmei Takaichi
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Kenichi Ohashi
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Takeshi Fujii
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| | - Yoshifumi Ubara
- From the Nephrology Center and Okinaka Memorial Institute for Medical Research, Department of Pathology, and Nephrology Center, Toranomon Hospital; Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.A. Endo, MD, Nephrology Center, Toranomon Hospital, and Division of Nephrology, Department of Internal Medicine, Kyorin University School of Medicine; J. Hoshino, MD; T. Suwabe, MD; K. Sumida, MD; K. Mise, MD; R. Hiramatsu, MD; E. Hasegawa, MD; M. Yamanouchi, MD; N. Hayami, MD; N. Sawa, MD, Nephrology Center, Toranomon Hospital; K. Takaichi, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research; K. Ohashi, MD, Nephrology Center; T. Fujii, MD, Department of Pathology; Y. Ubara, MD, Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital
| |
Collapse
|
12
|
Almouhawis HA, Leao JC, Fedele S, Porter SR. Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment. J Oral Pathol Med 2013; 42:507-16. [PMID: 23301777 DOI: 10.1111/jop.12030] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/17/2012] [Indexed: 01/31/2023]
Abstract
Wegener's granulomatosis (WG) is an idiopathic, systemic inflammatory disease characterized by necrotizing granulomatous inflammation and pauci-immune small-vessel vasculitis of upper and lower respiratory tract and kidneys. The condition affects both genders equally, although some inconsistent gender differences have been observed. The aetiology of WG remains unknown although a number of exogenous factors have been suggested to be of aetiological relevance. Most clinical characteristics of this disease are non-specific, making clinical diagnosis challenging. Histopathological examination of lesional and peritoneal tissue is not pathognomonic, but is an essential investigation to confirm the presence of disease and exclude other disorders. At present, despite the increasingly wide range of potential therapies, cyclophosphamide plus corticosteroids remain the most recognized and effective means of inducing and sustaining remission of WG.
Collapse
Affiliation(s)
- Hanan A Almouhawis
- Oral Medicine unit, Department of Maxillofacial Medicine and Surgery, UCL Eastman Dental Institute, London, UK
| | | | | | | |
Collapse
|
13
|
Vega Braga FL, Machado de Carvalho G, Caixeta Guimarães A, Scaramussa L, Jordão Gusmão R. Otolaryngological Manifestations of Wegener's Disease. ACTA OTORRINOLARINGOLOGICA ESPANOLA 2013. [DOI: 10.1016/j.otoeng.2013.02.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
14
|
Vega Braga FL, Machado de Carvalho G, Caixeta Guimarães A, Scaramussa L, Jordão Gusmão R. [Otolaryngological manifestations of Wegener's disease]. ACTA OTORRINOLARINGOLOGICA ESPANOLA 2012; 64:45-9. [PMID: 23063377 DOI: 10.1016/j.otorri.2012.07.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2012] [Revised: 07/02/2012] [Accepted: 07/17/2012] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Wegener's granulomatosis (WG) is characterised by granulomatous vasculitis of the airway and glomerulonephritis. Since its first description, important advances have occurred in diagnosis and treatment; however, the aetiology remains unknown. Involvement of the head and neck region can often occur as the first and only manifestation. The aim of this study was to determine the frequency of symptoms and signs in the region of the nose, ears and pharynx-larynx in a group of patients with WG. MATERIALS AND METHODS We evaluated 17 patients with WG defined by clinical, laboratory and pathology criteria. Detailed histories were taken and an ENT physical examination, audiometry, tympanometry and nasofibrolaryngoscopy were performed in all patients. RESULTS The average age was 41.7 years and the average disease time was 9.12 years, ranging between 1 and 40. In these patients, 9 (53.1%) reported hearing loss and had altered audiometry, and 5 (55.6%) had bilateral sensorineural hearing loss. In the nose, nasal obstruction in 11 (64.8%) and rhinorrhoea in 10 (58.8%) were the most prevalent; there was altered endoscopy in 12 (70.2%). In the pharynx-larynx, dyspnoea in 6 (35%) and hoarseness in 7 (41.2%) were the most prevalent and 7 (41%) had an altered laryngoscopy. CONCLUSION The otolaryngologist plays an essential role in diagnosis, treatment and follow-up of these patients. Knowing common symptoms makes diagnosis and treatment easier and earlier.
Collapse
Affiliation(s)
- Fabio Luis Vega Braga
- Department of Otolaryngology, Complejo Hospitalario Metropolitano Dr. Arnulfo Arias Madrid (CHDAAM), Panamá.
| | | | | | | | | |
Collapse
|
15
|
Vandergheynst F, Dumarey N, Cogan E. Relapse of a renal inflammatory pseudotumour associated with Wegener's granulomatosis. Acta Clin Belg 2010; 65:429-31. [PMID: 21268960 DOI: 10.1179/acb.2010.65.6.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
We report the case of a 32-year-old patient with Wegener's granulomatosis (WG) associated with a (biopsy - proven) renal inflammatory pseudotumour (IPT) of the left kidney treated by a partial nephrectomy, glucocorticoids and immunosuppressive drugs, in whom a relapse of renal IPT was found 6 years after the diagnosis of the first IPT. The originality of this observation lies in the fact that a relapse of IPT has never been described and also in the fact that complete regression of the IPT relapse was obtained with immunosuppressive treatment, while renal IPTs are currently treated by total or partial resection of the kidney. Finally, we discuss the potential benefits of an integrated 18fluorodeoxyglucose PET/CT for the follow-up of WG, since this imaging technique contributed to the management of the present case.
Collapse
Affiliation(s)
- F Vandergheynst
- Internal Medicine Department, C.H.U. Erasme, Université Libre de Bruxelles, Brussels, Belgium.
| | | | | |
Collapse
|
16
|
Abstract
Antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) comprises a group of systemic inflammatory vasculitides associated with circulating autoantibodies directed against the neutrophil granule components proteinase 3 and myeloperoxidase. ANCA interact with their target antigens on cytokine primed neutrophils, causing neutrophil activation via several signaling pathways that culminates in endothelial interaction, degranulation, cytokine production, and endothelial and tissue damage. The presence of autoantibodies implies the assistance of autoreactive T-helper cells and B cells, and a failure of regulatory mechanisms. This article reviews the current evidence for the pathogenic mechanisms culminating in autoantibody production, the effects of ANCA-neutrophil and neutrophil-endothelial interactions, and the mechanisms of tissue damage.
Collapse
Affiliation(s)
- Julia Flint
- Birmingham Children's Hospital NHS Foundation Trust, Birmingham B4 6NH, UK
| | | | | |
Collapse
|
17
|
de Souza FHC, Radu Halpern AS, Valente Barbas CS, Shinjo SK. Wegener's granulomatosis: experience from a Brazilian tertiary center. Clin Rheumatol 2010; 29:855-60. [PMID: 20195878 DOI: 10.1007/s10067-010-1408-4] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2009] [Revised: 02/05/2010] [Accepted: 02/12/2010] [Indexed: 10/19/2022]
Abstract
Most epidemiological studies with Wegener's granulomatosis (WG) patients are based on populations from the Northern hemisphere, whereas very few studies have been conducted in Southern hemisphere populations, particularly from South America. The authors performed a large retrospective, demographic study including clinical and laboratory profiles of 134 consecutive WG patients seen at one Brazilian center from 1999 to 2009. Mean age at initial WG diagnosis was 43.4 +/- 15.5 years, and mean disease duration was 8.6 +/- 6.6 years. Sixty-four (47.8%) patients were male and a total of 113 (84.3%) subjects were white. Ear/nose/throat involvement occurred in 85.8%. The classic lung and renal involvement were observed in 77.6% and 75.4%, respectively, followed by ocular (35.8%), musculoskeletal (33.4%), cutaneous (29.1%), neurological (20.1%), cardiac (11.2%), and genitourinary involvement in 2.2% of cases. Cytoplasmic pattern-antineutrophil cytoplasmic antibody was detected in 83 (61.9%) cases. Ten (7.5%) individuals presented limited forms of WG. Classic therapy with corticosteroids and cyclophosphamide was used in 97 cases (72.4%). There were no cases of tuberculosis or Pneumocystis jiroveci pneumonia, but cutaneous herpes zoster occurred in eight (6.0%) individuals. There were 29 deaths (21.6%). Eighteen patients died of septic shock (mainly bacterial pneumonia), whereas four died of alveolar hemorrhage, four of myocardial infarction, and three of other causes. In summary, our data from a very large retrospective and descriptive study mirrored the main clinical features of WG described in other countries, demonstrating that they may serve as a reference for South American populations.
Collapse
Affiliation(s)
- Fernando Henrique Carlos de Souza
- Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455, 3 degrees andar, Sala 3190, CEP 01246-903 São Paulo, Brazil
| | | | | | | |
Collapse
|
18
|
Harris MS, Moore MG. Seronegative Wegener granulomatosis. Otolaryngol Head Neck Surg 2010; 142:142-3. [PMID: 20096242 DOI: 10.1016/j.otohns.2009.08.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2009] [Revised: 08/06/2009] [Accepted: 08/17/2009] [Indexed: 10/20/2022]
Affiliation(s)
- Michael S Harris
- Department of Otolaryngology-Head and Neck Surgery, Indiana University, Indianapolis, IN, USA.
| | | |
Collapse
|
19
|
Minnee RC, van den Berk GEL, Groeneveld JO, van Dijk J, Turkcan K, Visser MJ, Vahl AC. Aortic aneurysm and orchitis due to Wegener's granulomatosis. Ann Vasc Surg 2009; 23:786.e15-9. [PMID: 19748223 DOI: 10.1016/j.avsg.2009.06.011] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2008] [Revised: 02/16/2009] [Accepted: 06/08/2009] [Indexed: 12/30/2022]
Abstract
We present a patient with Wegener's granulomatosis (WG) with involvement of the abdominal aorta, testis, peripheral nerve system, and skin. A 51-year-old man presented at our outpatient clinic with lower back pain. He had a history of smoking, hypertension, and an embryonal carcinoma of the left testis, treated 13 years ago with orchidectomy and chemotherapy. One month earlier, he underwent a partial orchidectomy of the right testis due to testicular swelling. Abdominal computed tomography showed a 3.8 cm wide aneurysm of the distal part of the aorta with inflammation. One week later he was admitted to the hospital with numbness of his hands and feet. Physical examination showed signs of peripheral microemboli. Serological laboratory tests revealed elevated antineutrophil cytoplasmic antibody titers with positive reactions against proteinase-3, indicating Wegener's disease. The chest X-ray was normal. Pathological examination of the right testis showed necrotizing vasculitis of a small artery. He was treated with cyclophosphamide and prednisolone. WG with extrapulmonary involvement occurs infrequently, and reports of manifestations of WG in aorta, testis, the peripheral nerve system, and skin are even more uncommon. Small- and medium-vessel vasculitis can precede large-vessel vasculitis or occur in the absence of small-vessel involvement. Therefore, WG should be included in the work-up of large-vessel vasculitis, which can give rise to periaortic inflammation.
Collapse
Affiliation(s)
- R C Minnee
- Department of Vascular Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands
| | | | | | | | | | | | | |
Collapse
|
20
|
|
21
|
Frigui M, Ben Hmida M, Kechaou M, Jlidi R, Bahloul Z. Wegener's granulomatosis presenting as multiple bilateral renal masses: case report and literature review. Rheumatol Int 2008; 29:679-83. [PMID: 18828022 DOI: 10.1007/s00296-008-0715-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2008] [Accepted: 09/07/2008] [Indexed: 11/30/2022]
Abstract
Wegener's granulomatosis (WG) is a disease of unknown etiology characterized by necrotizing granulomatous vascularitis. The upper and lower respiratory tract and kidney involvements are very common; however, its presentation as bilateral renal masses is unusual. We report a case of a 59-year-old female patient who presented with multiple bilateral renal masses. The patient presented with sinusal and ocular symptoms suggestive of WG, and positive antineutrophil cytoplasmic antibodies (c-ANCA) with an anti-PR3 pattern. Histopathologic examination of the renal biopsy specimen revealed granulomatous inflammation with vasculitis and fibrinoid necrosis. The patient management, including prednisone and cyclophosphamid, induced a marked improvement of the renal masses. This case illustrates that WG should be considered in the differential diagnosis of renal masses.
Collapse
Affiliation(s)
- Makram Frigui
- Department of Internal Medicine, Hédi Chaker Hospital, Sfax, Tunisia.
| | | | | | | | | |
Collapse
|
22
|
Matsumoto T, Kaneko T, Seto M, Wada H, Kobayashi T, Nakatani K, Tonomura H, Tono Y, Ohyabu M, Nobori T, Shiku H, Sudo A, Uchida A, Kurosawa DJS, Kurosawa S. The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis. Clin Appl Thromb Hemost 2008; 14:186-92. [PMID: 18372277 DOI: 10.1177/1076029607303961] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Proteinase 3 (PR3) expression on neutrophils was examined in rheumatoid arthritis (RA) patients before and after antitumor necrosis factor (TNF)-alpha therapy. Membrane PR3 expression from patients with either an infection or RA significantly increased. Membrane PR3 expression on neutrophils from RA patients treated with infliximab (anti-TNF-alpha antibody) therapy was less than in those without such treatment in a resting state, but the expression later increased after stimulation in vitro. Membrane PR3 expression increased because of the stimulation of TNFalpha, whereas it was significantly suppressed by plasma or alpha(1)-proteinase inhibitor. The condition of patients with RA improved after treatment with infliximab. Membrane PR3 expression on neutrophils in RA patients was downregulated by infliximab. As a result, PR3 might play an important role in the neutrophil-mediated inflammatory reaction in patients with either RA or an infection.
Collapse
Affiliation(s)
- Takeshi Matsumoto
- Department of Hematology and Oncology, Patient Safety Division, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Javaud N, Belenfant X, Stirnemann J, Laederich J, Ziol M, Callard P, Ronco P, Rondeau E, Fain O. Renal granulomatoses: a retrospective study of 40 cases and review of the literature. Medicine (Baltimore) 2007; 86:170-180. [PMID: 17505256 DOI: 10.1097/md.0b013e3180699f55] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Renal granulomatoses represent 0.5%-0.9% of nephropathies examined by renal biopsies. Granulomas can be isolated to the kidney or associated with other tissue involvement. We describe 40 consecutive patients with renal granulomatoses, associated with pauci-immune crescentic glomerulonephritis in 2 patients and with vasculitis in another, seen in northeastern Paris hospitals between January 1991 and February 2004. The criterion for inclusion was the presence of 1 or more epithelioid granulomas in the renal interstitium. Our population of 25 men and 15 women had a median age of 53 years. All patients suffered from renal insufficiency with median creatininemia of 236.8 micromol/L (range, 124-805 micromol/L), associated with hypertension (25%), median proteinuria of 0.6 g/24 h (range, 0.08-3.00 g/24 h), microscopic hematuria (15%) and leukocyturia (22.5%). Histologic examination of extrarenal specimens detected granulomas in 82.4% of the bronchial biopsies taken, and in 100% of the 2 skin biopsies, the 2 lymph-node biopsies, and the liver and colon biopsies. The following etiologies were retained: sarcoidosis for 20 (50%) patients, drug-induced for 7 (17.5%), tuberculosis for 3 (7.5%), Wegener granulomatosis for 2 (5%), and leprosy, Mycobacterium avium infection, and Crohn disease for 1 (2.5%) patient each. No etiology could be identified for 5 (12.5%) patients. Treatment must be adapted to the etiology of each case. The renal outcome after treatment was generally favorable, with the estimated median creatinine clearance increasing from 26 mL/min (range, 5.4-80.0 mL/min) to 46.5 mL/min (range, 0-118 mL/min) after a median follow-up of 35.5 months (range, 3-158 mo). Nonetheless, 32 patients had persistent renal insufficiency; 1 required hemodialysis and another underwent renal transplantation. Sarcoidosis and medications are the most common causes of renal granulomatosis. Idiopathic and drug-induced forms do not relapse after treatment discontinuation, and remission persists at long-term follow-up.
Collapse
Affiliation(s)
- Nicolas Javaud
- From Service de Médecine Interne (NJ, JS, OF) and Service d'Anatomie et de Cytologie Pathologique (MZ), AP-HP, Hôpital Jean-Verdier, Bondy; Université Léonard De Vinci-Paris 13 (MZ, OF), Bobigny; Service de Néphrologie (NJ, XB, JL), Hôpital Intercommunal André-Grégoire, Montreuil; Service d'Anatomie et de Cytologie Pathologique (PC), Service de Néphrologie et Dialyses (PR), and Service d'Urgences Néphrologiques et Transplantation Rénale (ER), AP-HP, Hôpital Tenon, Paris; and Université Pierre et Marie Curie-Paris 6 (PC,ER, PR), Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
A broad and diverse spectrum of vasculitic syndromes exists. These syndromes affect the skin with varying levels of associated systemic manifestations, running the gamut from a self-limited, localized, cutaneous phenomenon to rapidly progressive, multiorgan disease. The majority of cases of cutaneous vasculitis will show a neutrophilic small vessel vasculitis that can be either a primary (idiopathic) disorder (eg, cutaneous leukocytoclastic angiitis) or a secondary disorder that is associated with drugs, infection (eg, streptococcal infection, viral hepatitis), or underlying disease (eg, connective tissue disease, malignancy). Biopsy is the gold standard for the diagnosis of cutaneous vasculitis and also necessary for the detection of cutaneous vascular immune complexes by direct immunofluorescence. Based on the type of vessel disrupted by inflammation (small and/or muscular), the distribution of vasculitis in the dermis and subcutis, and predominate inflammatory cell-type mediating vessel wall damage, a list of relevant differential diagnoses can be generated. This histologic information coupled with extravascular findings such as tissue eosinophilia, tissue neutrophilia, and/or granulomas, plus pathophysiologic markers such as direct immunofluorescent examination for immune complexes and serologic evaluation for antineutrophil cytoplasmic antibodies allows for more accurate diagnosis of specific vasculitic entities. Herein, we review both primary and secondary vasculitic syndromes that affect the skin and show a small vessel neutrophilic mediated vasculitis.
Collapse
Affiliation(s)
- J Andrew Carlson
- Divisions of Dermatology and Dermatopathology, Albany Medical College, Albany, NY 12208, USA.
| | | |
Collapse
|
25
|
Wittekindt C, Lüers JC, Drebber U, Guntinas-Lichius O, Hüttenbrink KB. [ANCA-negative subglottic laryngeal stenosis in childhood]. HNO 2006; 55:807-11. [PMID: 17082959 DOI: 10.1007/s00106-006-1457-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
A 15-year-old female, having developed recurrent infections of the upper airway, hoarseness, dyspnea, and nasal congestion, was referred to our department. There was no history of trauma or intubation. The subglottic space was circularly narrowed. The test for c-ANCA was negative. Chest X-ray and renal function were normal. A tracheotomy was performed; the histology showed infiltrating plasma cells, but no signs of vasculitis or granulomatous inflammation. One year later the patient developed acute renal failure. Biopsy of the kidney confirmed Wegener's disease. The laryngeal stenosis completely resolved after therapy with cyclophosphamide. Juvenile Wegener's granulomatosis is extremely rare; the larynx and trachea seem to be involved more frequently in children than in adults. The positive testing of c-ANCA can support the diagnosis; however, even when c-ANCA do not test positive, the disease can never be excluded. Surgical interventions within the larynx or trachea might only be considered after ineffective therapy with immunosuppressive drugs.
Collapse
Affiliation(s)
- C Wittekindt
- Klinik und Poliklinik für Hals-, Nasen-, Ohren-Heilkunde, Kopf- und Hals-Chirurgie am Klinikum der Universität zu Köln.
| | | | | | | | | |
Collapse
|
26
|
Matsumoto T, Kaneko T, Wada H, Kobayashi T, Abe Y, Nobori T, Shiku H, Stearns-Kurosawa DJ, Kurosawa S. PROTEINASE 3 EXPRESSION ON NEUTROPHIL MEMBRANES FROM PATIENTS WITH INFECTIOUS DISEASE. Shock 2006; 26:128-33. [PMID: 16878019 DOI: 10.1097/01.shk.0000223122.11147.5a] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Proteinase-3 (PR3) is an abundant serine proteinase stored in the azurophilic granules of neutrophils and released to the cell surface upon activation where it contributes to local tissue destruction and inflammation. The sub-population of membrane PR3 (mPR3) high expression (PR3-high) varies among individuals. There are many reports about PR3 in Wegener's granulomatosis, but few about PR3 expression in patients with common inflammatory disorders, such as sepsis. The mPR3 expression on neutrophils from 56 patients with inflammatory disorders and from 64 healthy volunteers was examined by flow cytometry. High variability in the percentage of PR3-high (%PR3-high) neutrophils was observed in healthy volunteers and patients with inflammatory disease, and the %PR3-high was significantly greater in the patients (72 +/- 19% vs 55 +/- 20%, P < 0.0001). Overall neutrophil PR3 expression in patients with infectious diseases, especially systemic inflammatory response syndrome (SIRS) was significantly high (P < 0.01) and showed a positive correlation with C-reactive protein (CRP). Even under inflammatory conditions not involving autoimmune vasculitis, there are significant increases in both the absolute surface expression of PR3 and the numbers of neutrophils expressing high levels of PR3 and these correlate with CRP levels. The data are consistent with a model in which neutrophil membrane expression of PR3 is greatly influenced by an in vivo inflammatory environment.
Collapse
Affiliation(s)
- Takeshi Matsumoto
- Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu City, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
de Lind van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DRW, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM. Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis: A Prospective Analysis of 100 Patients with Severe Renal Involvement. J Am Soc Nephrol 2006; 17:2264-74. [PMID: 16825335 DOI: 10.1681/asn.2005080870] [Citation(s) in RCA: 184] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
This study aimed to identify clinical and histologic prognostic indicators of renal outcome in patients with ANCA-associated vasculitis and severe renal involvement (serum creatinine >500 micromol/L). One hundred patients who were enrolled in an international, randomized, clinical trial to compare plasma exchange with intravenous methylprednisolone as an additional initial treatment were analyzed prospectively. Diagnostic renal biopsies were performed upon entry into the study. Thirty-nine histologic and nine clinical parameters were determined as candidate predictors of renal outcome. The end points were renal function at the time of diagnosis (GFR0) and 12 mo after diagnosis (GFR12), dialysis at entry and 12 mo after diagnosis, and death. Multivariate analyses were performed. Predictive of GFR0 were age (r = -0.40, P = 0.04), arteriosclerosis (r = -0.53, P = 0.01), segmental crescents (r = 0.35, P = 0.07), and eosinophilic infiltrate (r = -0.41, P = 0.04). Prognostic indicators for GFR12 were age (r = -0.32, P = 0.01), normal glomeruli (r = 0.24, P = 0.04), tubular atrophy (r = -0.28, P = 0.02), intraepithelial infiltrate (r = -0.26, P = 0.03), and GFR0 (r = 0.29, P = 0.01). Fibrous crescents (r = 0.22, P = 0.03) were predictive of dialysis at entry. Normal glomeruli (r = -0.30, P = 0.01) and treatment arm (r = -0.28, P = 0.02) were predictive of dialysis after 12 mo. No parameter predicted death. Both chronic and acute tubulointerstitial lesions predicted GFR12 in severe ANCA-associated glomerulonephritis, whereas plasma exchange was a positive predictor of dialysis independence after 12 mo for the entire patient group. Plasma exchange remained a positive predictor when patients who were dialysis dependent at presentation were analyzed separately (r = -0.36, P = 0.01). Normal glomeruli were a positive predictor of dialysis independence and improved renal function after 12 mo, indicating that the unaffected part of the kidney is vital in determining renal outcome.
Collapse
|
28
|
Khan AM, Elahi F, Hashmi SR, Mahida KH, Ingrams DR. Wegener's granulomatosis: a rare, chronic and multisystem disease. Surgeon 2006; 4:45-52. [PMID: 16459500 DOI: 10.1016/s1479-666x(06)80021-1] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Wegener's granulomatosis (WG) is an autoimmune disease which has a clinical predilection for the upper airways, lungs and kidneys. It is a necrotising granulomatous vasculitis which is associated with a distinct autoantibody--the antineutrophil cytoplasmic antibody (ANCA). A heightened index of suspicion by clinicians is needed in the diagnosis of this complex and rare condition. A multidisciplinary approach should then be used to treat this chronic multisystem disease. Treatment involves the use of various regimens of corticosteroids and immunosuppressive medication. Mortality due to WG has been significantly decreased by this therapy. In this article, we focus on clinical manifestations and review the salient histologic, laboratory and serologic features and treatment.
Collapse
Affiliation(s)
- A M Khan
- Department of ENT, Royal Gwent Hospital, Newport, South Wales.
| | | | | | | | | |
Collapse
|
29
|
Carlson JA, Ng BT, Chen KR. Cutaneous Vasculitis Update: Diagnostic Criteria, Classification, Epidemiology, Etiology, Pathogenesis, Evaluation and Prognosis. Am J Dermatopathol 2005; 27:504-28. [PMID: 16314707 DOI: 10.1097/01.dad.0000181109.54532.c5] [Citation(s) in RCA: 155] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Vasculitis, inflammation of the vessel wall, can result in mural destruction with hemorrhage, aneurysm formation, and infarction, or intimal-medial hyperplasia and subsequent stenosis leading to tissue ischemia. The skin, in part due to its large vascular bed, exposure to cold temperatures, and frequent presence of stasis, is involved in many distinct as well as un-named vasculitic syndromes that vary from localized and self-limited to generalized and life-threatening with multi-organ disease. To exclude mimics of vasculitis, diagnosis of cutaneous vasculitis requires biopsy confirmation where its acute signs (fibrinoid necrosis), chronic signs (endarteritis obliterans), or past signs (acellular scar of healed arteritis) must be recognized and presence of extravascular findings such as patterned fibrosis or collagenolytic granulomas noted. Although vasculitis can be classified by etiology, many cases have no identifiable cause, and a single etiologic agent can elicit several distinct clinicopathologic expressions of vasculitis. Therefore, the classification of cutaneous vasculitis is best approached morphologically by determining vessel size and principal inflammatory response. These histologic patterns roughly correlate with pathogenic mechanisms that, when coupled with direct immunofluorescent examination, anti-neutrophil cytoplasmic antibody (ANCA) status, and findings from work-up for systemic disease, allow for specific diagnosis, and ultimately, more effective therapy. Herein, we review cutaneous vasculitis focusing on diagnostic criteria, classification, epidemiology, etiology, pathogenesis, and evaluation of the cutaneous vasculitis patient.
Collapse
Affiliation(s)
- J Andrew Carlson
- Division of Dermatology, Albany Medical College, Albany, New York 12208, USA.
| | | | | |
Collapse
|
30
|
Cadoni G, Prelajade D, Campobasso E, Calŏ L, Agostino S, Manna R, Paludetti G. Wegener's granulomatosis: a challenging disease for otorhinolaryngologists. Acta Otolaryngol 2005; 125:1105-10. [PMID: 16298794 DOI: 10.1080/00016480510028500] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Diagnosis of Wegener's granulomatosis (WG) can be delayed because of its aspecific presenting symptoms. Detection of serum circulating antineutrophil cytoplasm antibodies (c-ANCAs), in combination with histology, permits one to identify WG at an early stage and to implement stage-adapted therapy. c-ANCA levels may also help to evaluate the response to medical therapy. Recently, the quality of life of WG patients has been improved by administering cotrimoxazole in order to prevent infections and recurrent diseases during the remission period.WG is of special significance to the otorhinolaryngologist because it is often initially limited to the upper respiratory tract before becoming systemic. The aim of this paper was to describe a series of WG patients and underline the difficulties involved in diagnosing and treating this challenging disease. This was a prospective study in 23 consecutive patients with head and neck manifestations of WG (17 systemic, 6 limited). Diagnosis was performed by means of both c-ANCAs detection using indirect immunofluorescence and histology in biopsy specimens. Treatment consisted of daily cyclophosphamide (CYC; 2 mg/kg/day) and glucocorticoids (prednisone; 1 mg/kg/day). If an improvement or toxic events occurred, CYC was discontinued and methotrexate was started. If, during remission of the disease, low serum c-ANCAs levels were detected, CYC was suspended and cotrimoxazole (1 g/day) was introduced. Serum c-ANCAs detection was positive for all patients. Biopsy was diagnostic from the beginning in 19/23 cases. The six patients with limited WG did not show a progression to systemic disease. Only 3 patients with a diagnosis of delayed systemic WG died, whereas 19/23 patients were alive with good control of relapses.
Collapse
Affiliation(s)
- Gabriella Cadoni
- Department of Otorhinolaryngology, Catholic University of the Sacred Heart, Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
31
|
Samarkos M, Loizou S, Vaiopoulos G, Davies KA. The Clinical Spectrum of Primary Renal Vasculitis. Semin Arthritis Rheum 2005; 35:95-111. [PMID: 16194695 DOI: 10.1016/j.semarthrit.2005.05.004] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND AND OBJECTIVES The vasculitides are potentially severe and often difficult to diagnose syndromes. Many forms of vasculitis may involve the kidneys. This review will focus on the clinical and histopathological aspects of renal involvement in the systemic vasculitides. METHODS We searched the MEDLINE database using as key terms the MeSH terms and textwords for different forms of vasculitis and for renal involvement, creating a database of more than 2200 relevant references. RESULTS The frequency of renal involvement in vasculitis varies among different syndromes. It is more frequent in Wegener's granulomatosis and microscopic polyarteritis, while it is uncommon to rare in other forms of vasculitis such as Behçet's disease and relapsing polychondritis. The vessels affected include the renal artery in Takayasu arteritis, medium-size renal parenchymal artery in classic polyarteritis nodosa, and glomerular involvement in Wegener's granulomatosis and microscopic polyarteritis. The clinical expression of renal vasculitis depends on the size of the affected vessels and includes renovascular hypertension, isolated nonnephrotic proteinuria, interstitial nephritis, and glomerulonephritis, which can be rapidly progressive. Diagnosis is established by a combination of history, clinical manifestations, laboratory findings (eg, urine sediment, urine protein, antineutrophil cytoplasmic antibodies), imaging techniques (renal angiography, especially when there is a suspicion of medium-to-large vessel disease, and chest radiograph), and finally, renal biopsy. Prognosis varies from unfavorable in the rapidly progressive glomerulonephritis of microscopic polyarteritis, which can lead to renal failure, chronic dialysis, and renal transplantation, to benign, as in the case of Henoch Schonlein purpura, in which the majority of patients recover. CONCLUSIONS The manifestations and prognosis of renal vasculitis range widely. Renal involvement greatly influences prognosis and dictates the need for early and prompt immunosuppressive therapy. Thus, the clinician should be alert for the timely diagnosis and treatment of renal vasculitis.
Collapse
Affiliation(s)
- Michael Samarkos
- 5th Department of Internal Medicine, Evangelismos Hospital, Athens, Greece.
| | | | | | | |
Collapse
|
32
|
Guilpain P, Servettaz A, Tamby MC, Chanseaud Y, Le Guern V, Guillevin L, Mouthon L. Pathogénie des vascularites systémiques primitives (II): vascularites ANCA-négatives. Presse Med 2005; 34:1023-33. [PMID: 16225258 DOI: 10.1016/s0755-4982(05)84105-3] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
The pathogenesis of different types of systemic vasculitis negative for antineutrophil cytoplasm antibodies (ANCA) and involving small or medium-sized vessels is not very well documented. During polyarteritis nodosa (PAN), which is related to hepatitis B virus (HBV) infection, as well as during cryoglobulinemic vasculitides, associated with hepatitis C virus (HCV), and probably during Henoch Schönlein purpura, histological lesions may result from the deposition of immune complexes formed from viral antigens and from antibodies responsible for the activation of the classic complement pathway and for recruitment of polymorphonuclear neutrophils. Two other mechanisms are discussed for other types of ANCA-negative systemic vasculitis: immune complex deposition and sheer stress at arterial bifurcation points. A bacterial superantigen is suspected in Kawasaki disease but remains unproved.
Collapse
Affiliation(s)
- P Guilpain
- Université Paris-Descartes, Faculté de médecine, UPRES EA 1833, site Cochin, Paris
| | | | | | | | | | | | | |
Collapse
|
33
|
Badakere SS, Pradhan VD, Almeida AF, Pawar AR. Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3. J Fluoresc 2005; 14:459-63. [PMID: 15617388 DOI: 10.1023/b:jofl.0000031827.75873.a4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Anti-neutrophil cytoplasmic antibodies (ANCA) are the immunodiagnostic markers for idiopathic necrotizing crescentic glomerulonephritis affecting mainly medium to small sized blood vessels. The diagnosis of ANCA associated vasculitis (AAV) is mainly based on clinical and histopathological characteristics along with the serological evidence. Immunofluorescence microscopy (IIF) is considered as the "gold standard" for ANCA detection, and ANCA showing two major patterns ie, cytoplasmic (c-ANCA) and perinuclear (p-ANCA) react with different antigenic targets of neutrophils like Proteinase3 (PR3) and Myeloperoxidase (MPO). A third unusual and rare immunofluorescence pattern called as "X- ANCA" or atypical ANCA is also sometimes seen. The difficulty in identification of ANCA immunofluorescence patterns is mainly seen due to the rare dual patterns seen in the same sera and also the additional nuclear immunofluorescence seen due to presence of anti-nuclear antibodies. ANCA testing by immunofluorescence and Confocal Laser scanning microscopy, as well as by specific ELISAs for detection of anti-PR3 and anti-MPO antibodies have helped in improving the diagnosis. Patients having dual specificities to MPO and PR3 in a patient is a rare finding. Among 425 clinically and histopathologically proven cases of AAV, eight patients (1.9%) had dual specificities, of which five patients showed mixed immunofluorescence pattern and 3 patients showed X-ANCA pattern which was confirmed by both immunofluorescence and Confocal Laser scanning microscopy and the dual specificities to MPO and PR3 were detected by individual ELISAs.
Collapse
Affiliation(s)
- S S Badakere
- Department of Autoimmune disorders, Institute of Immunohaematology, Indian Council of Medical Research, King Edward Memorial Hospital, 13th floor, Parel, Mumbai 400 012, India.
| | | | | | | |
Collapse
|
34
|
Marten K, Schnyder P, Schirg E, Prokop M, Rummeny EJ, Engelke C. Pattern-Based Differential Diagnosis in Pulmonary Vasculitis Using Volumetric CT. AJR Am J Roentgenol 2005; 184:720-33. [PMID: 15728589 DOI: 10.2214/ajr.184.3.01840720] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Affiliation(s)
- Katharina Marten
- Department of Radiology, Klinikum rechts der Isar, Technical University Munich, Ismaningerstrasse 22, Munich 81675, Germany.
| | | | | | | | | | | |
Collapse
|
35
|
Mathai SS, Bawa KS, Tampi PS, Bhandari A, Mishra RN. Wegener's Granulomatosis with Fungal Lung Infection in a Child. Med J Armed Forces India 2005; 61:71-3. [PMID: 27407708 DOI: 10.1016/s0377-1237(05)80125-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2003] [Accepted: 05/08/2003] [Indexed: 10/18/2022] Open
Affiliation(s)
- S S Mathai
- Classified Specialist (Pediatrics & Neonatology), INHS Asvini, Colaba, Mumbai
| | - K S Bawa
- Ex-Senior Adviser (Paediatrics), INHS Asvini, Colaba, Mumbai
| | - P S Tampi
- Classified Specialist (Medicine & Respiratory Medicine), INHS Asvini, Colaba, Mumbai
| | - A Bhandari
- Graded Specialist (Paediatrics), INHS Kalyani, Visakhapatnam
| | - R N Mishra
- Senior Adviser (Pathology & Microbiology), INHS Asvini, Colaba, Mumbai
| |
Collapse
|
36
|
Gubbels SP, Barkhuizen A, Hwang PH. Head and neck manifestations of Wegener's granulomatosis. Otolaryngol Clin North Am 2003; 36:685-705. [PMID: 14567060 DOI: 10.1016/s0030-6665(03)00023-9] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Wegener's granulomatosis is an idiopathic, granulomatous disease with the potential for multiple head and neck manifestations. The otolarygologist is an essential part of the multidisciplinary team involved in establishing the diagnosis and providing ongoing care for patients with Wegener's granulomatosis. Diagnostic difficulties abound in Wegener's granulomatosis, making repeat biopsies and the use of ANCA imperative. Medical therapy consisting of corticosteroids and immunosuppressive agents is the mainstay of treatment in Wegener's granulomatosis, whereas surgery is reserved for selected head and neck manifestations. With appropriate medical and surgical treatment, many patients living with Wegener's granulomatosis can enjoy a good quality of life.
Collapse
Affiliation(s)
- Samuel P Gubbels
- Department of Otolaryngology/Head and Neck Surgery, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | | | | |
Collapse
|
37
|
Takwoingi YM, Dempster JH. Wegener's granulomatosis: an analysis of 33 patients seen over a 10-year period. CLINICAL OTOLARYNGOLOGY AND ALLIED SCIENCES 2003; 28:187-94. [PMID: 12755753 DOI: 10.1046/j.1365-2273.2003.00683.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
This retrospective study examined 33 patients with Wegener's granuloma seen between 1990 and 1999 in the Ayrshire and Arran region of Scotland. There was an estimated annual incidence of 10/million/year. The diagnosis in this series was based on the presence of one or more of the following: a positive histology, a positive c-ANCA or a typical clinical course. Twenty-eight patients were diagnosed based on either a positive histology and/or c-ANCA, whereas the remaining five were diagnosed based on the clinical course. c-ANCA was positive in 79.3% but correlated poorly with disease activity. Nasal biopsies were positive in 40%, whereas 94% of renal biopsies were positive, thereby making nasal biopsies unreliable in the diagnosis. Significantly elevated levels of erythrocyte sedimentation rate (ESR) averaging 77 mm/h were found in 32 patients at diagnosis. This showed fluctuation with disease activity. Thirteen patients died, 12 within 5 years. The best prognostic indicator statistically was age.
Collapse
Affiliation(s)
- Y M Takwoingi
- Department of Otolaryngology, Crosshouse Hospital, Kilmarnock, UK.
| | | |
Collapse
|
38
|
Shiboski CH, Regezi JA, Sanchez HC, Silverman S. Oral lesions as the first clinical sign of microscopic polyangiitis: a case report. ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, ORAL RADIOLOGY, AND ENDODONTICS 2002; 94:707-11. [PMID: 12464895 DOI: 10.1067/moe.2002.129178] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Microscopic polyangiitis (MPA) is defined as a systemic necrotizing vasculitis that clinically and histologically affects small-sized vessels without granulomata. The main clinical feature of MPA is renal involvement characterized by rapidly progressing glomerulonephritis. We report a case of oral lesions, initially thought to be associated with Wegener's granulomatosis, as the first sign of MPA in an otherwise healthy man. To our knowledge, this is the first published case of MPA-associated oral lesions.
Collapse
Affiliation(s)
- Caroline H Shiboski
- Department of Stomatology, School of Dentistry, University Of California San Francisco, 94143-0422, USA.
| | | | | | | |
Collapse
|
39
|
Bajema IM, Hagen EC, Ferrario F, de Heer E, Bruijn JA. Immunopathological aspects of systemic vasculitis. SPRINGER SEMINARS IN IMMUNOPATHOLOGY 2001; 23:253-65. [PMID: 11591101 DOI: 10.1007/s002810100074] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- I M Bajema
- Department of Pathology, Erasmus University Medical Center Rotterdam, Josephine Nefkens Institute, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
| | | | | | | | | |
Collapse
|
40
|
Kurosawa S, Esmon CT, Stearns-Kurosawa DJ. The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 2000; 165:4697-703. [PMID: 11035113 DOI: 10.4049/jimmunol.165.8.4697] [Citation(s) in RCA: 101] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
The protein C pathway is a primary regulator of blood coagulation and a critical component of the host response to inflammatory stimuli. The most recent member of this pathway is the endothelial protein C receptor (EPCR), a type I transmembrane protein with homology to CD1d/MHC class I proteins. EPCR accelerates formation of activated protein C, a potent anticoagulant and antiinflammatory agent. The current study demonstrates that soluble EPCR binds to PMA-activated neutrophils. Using affinity chromatography, binding studies with purified components, and/or blockade with specific Abs, it was found that soluble EPCR binds to proteinase-3 (PR3), a neutrophil granule proteinase. Furthermore, soluble EPCR binding to neutrophils was partially dependent on Mac-1 (CD11b/CD18), a beta(2) integrin involved in neutrophil signaling, and cell-cell adhesion events. PR3 is involved in multiple diverse processes, including hemopoietic proliferation, antibacterial activity, and autoimmune-mediated vasculitis. The observation that soluble EPCR binds to activated neutrophils via PR3 and a beta(2) integrin suggests that there may be a link between the protein C anticoagulant pathway and neutrophil functions.
Collapse
Affiliation(s)
- S Kurosawa
- Cardiovascular Biology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
| | | | | |
Collapse
|
41
|
Abstract
Systematic reviews and meta-analyses are techniques of data retrieval and analysis which complement traditional narrative reviews. They are widely used in clinical medicine and are finding an increasing role in anatomical pathology. Performing high quality systematic review and meta-analysis requires the accumulation of large numbers of cases from well planned and executed studies and is facilitated if data is presented in a standardized manner. Techniques which allow data from individual patients included in a variety of different studies are now being developed indicating that in future research papers may require a more detailed description of results than in the past. This need may be met by posting anonymised data on the Internet. Systematic reviews and meta-analyses are never complete since data are continually contributed and analyses constantly updated. As with any research paper, the results of these techniques require careful evaluation and the role of the expert reviewer is enlarged by these methodologies.
Collapse
Affiliation(s)
- M K Heatley
- Department of Pathology, The Royal Liverpool Hospital, UK
| |
Collapse
|
42
|
Murray A, McGarry GW. The clinical value of septal perforation biopsy. CLINICAL OTOLARYNGOLOGY AND ALLIED SCIENCES 2000; 25:107-9. [PMID: 10816212 DOI: 10.1046/j.1365-2273.2000.00332.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Biopsy from the edge of a septal perforation is performed to diagnose potentially significant aetiological conditions, including malignant pathology and Wegener's granulomatosis. However, it is common for the histological result to be undiagnostic and unhelpful in planning an individual patient's management. To clarify the role of septal perforation biopsy, we reviewed all biopsies performed on our patients over a 13-year period. Of the 65 biopsies performed, in 63 patients, none had a histological result which changed the clinical diagnosis made before biopsy. Forty-three patients had clinically benign perforations biopsied, and no histology other than chronic inflammation was obtained. In 16 patients with a clinical vasculitis, none had this diagnosis confirmed histologically. One positive biopsy was obtained from two patients with clinically malignant perforations yet both were treated for T-cell lymphoma. The subsequent management of all patients was based on their clinical diagnosis rather than their biopsy results. We suggest only clinically malignant perforations are worthwhile biopsying.
Collapse
Affiliation(s)
- A Murray
- Department of Otolaryngology/Head and Neck Surgery, Glasgow Royal Infirmary, Glasgow, UK
| | | |
Collapse
|
43
|
Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000; 57:846-62. [PMID: 10720938 DOI: 10.1046/j.1523-1755.2000.057003846.x] [Citation(s) in RCA: 165] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
There have been a number of recent advances in this field. First, the "International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)" has been developed to optimize ANCA testing. It requires that all sera are tested by indirect immunofluorescent (IIF) examination of normal peripheral blood neutrophils and, where there is positive fluorescence, in enzyme-linked immunosorbent assays (ELISAs) for antibodies against both proteinase 3 (PR3) and myeloperoxidase (MPO). Testing will be further improved when international standards and common ELISA units are available. Second, new diagnostic criteria for the small vessel vasculitides that take into account ANCA-positivity and target antigen specificity as well as histologic features are currently being produced. Third, we understand that the complications associated with treatment of the ANCA-associated vasculitides are often more hazardous than the underlying disease, and regimens that use effective but less toxic agents are being evaluated. The factors associated with increased risk of relapse, however, remain incompletely understood. Finally, ANCA with specificities other than PR3 and MPO are present in many nonvasculitic autoimmune diseases. Their clinical significance is still largely unclear, and some of the target antigens are present in other cells as well as neutrophils and thus are not strictly "ANCA."
Collapse
Affiliation(s)
- J Savige
- Department of Medicine, University of Melbourne, Austin, Australia.
| | | | | | | | | |
Collapse
|
44
|
Abstract
Wegener's granulomatosis is a multisystem disease characterized by granulomata of the respiratory tract and systemic necrotising vasculitis. There is a strong and specific association with autoantibodies directed against proteinase 3, a constituent of neutrophril azurophilic granules. Antibody titers correlate with clinical disease activity and predict relapses. The disease responds favorably to immunosuppressive therapy. The pathogenicity of antineutrophil cytoplasmic antibodies (ANCA), however, remains unproven. In vitro, the expression of proteinase-3 and other ANCA antigens on the surface of neutrophils and monocytes can be induced by priming with proinflammatory cytokines. Antineutrophil cytoplasmic antibodies are then able to activate these leukocytes, stimulating degranulation, the production of reactive oxygen species, and the secretion of further cytokines. Neutrophils activated by ANCA, and possibly ANCA alone, directly damage endothelial cells in vitro. An animal model of proteinase 3-ANCA-induced vasculitis has not been found. Antineutrophil cytoplasmic antibodies directed against another antigen, myeloperoxidase, are not sufficient to cause vasculitis but they promote damage in certain animal models. Thus, a considerable amount of evidence supports the notion that Wegener's granulomatosis is an autoimmune disease.
Collapse
Affiliation(s)
- P Hewins
- Division of Medical Sciences, MRC Centre for Immune Regulation, The Medical School, University of Birmingham, Edgbaston, UK
| | | | | | | |
Collapse
|
45
|
Taylor CT, Buring SM, Taylor KH. Treatment of Wegener's granulomatosis with immune globulin: CNS involvement in an adolescent female. Ann Pharmacother 1999; 33:1055-9. [PMID: 10534218 DOI: 10.1345/aph.18439] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
OBJECTIVE To describe the use of intravenous immune globulin (IVIG) to treat Wegener's granulomatosis (WG) in an adolescent female with an abnormal magnetic resonance imaging (MRI) scan and electroencephalogram (EEG), as well as central nervous system involvement manifesting as generalized seizures. CASE SUMMARY A 15-year-old white girl diagnosed with WG and receiving prednisone and cyclophosphamide was admitted with new-onset tonic-clonic seizures. The patient received phenobarbital and phenytoin to control seizures and was receiving cyclophosphamide and corticosteroids for WG. She developed cyclophosphamide-induced cystitis and was started on a four-day therapeutic course of IVIG following the discontinuation of cyclophosphamide. After 16 days of hospitalization, repeat EEG and MRI were within normal limits, and laboratory and clinical improvement was evident in at least nine of the affected organ systems including pulmonary, hematologic, renal, ocular, cutaneous, musculoskeletal, central nervous system, gastrointestinal, and genitourinary. The patient was discharged with clinical involvement of WG documented in two organ systems, hematologic and renal. DISCUSSION WG is a form of vasculitis believed to develop due to an autoimmune disorder. The diagnosis is based on radiographic and histopathologic findings, as well as the presence of elevated antineutrophil cytoplasmic antibodies and a suggestive clinical presentation. The presentation is widely variable and is most commonly associated with upper-airway involvement such as sinusitis, cough, pulmonary infiltrates, and cavitary nodules. Renal involvement signifies generalized disease. Conventional treatment for WG includes cyclophosphamide and prednisone. Little information is available describing therapeutic alternatives. Cytotoxicity related to immunosuppressant regimens limits continuous treatment and may necessitate the use of alternative agents. CONCLUSIONS This case describes the use of IVIG in an adolescent patient presenting with WG as a generalized, active disease with neurologic complications. IVIG may be useful in generalized, active WG complicated by intolerance to cyclophosphamide and seizures, but further study is necessary to define its role.
Collapse
Affiliation(s)
- C T Taylor
- Department of Pharmacy Practice, School of Pharmacy, Auburn University, AL, USA.
| | | | | |
Collapse
|
46
|
Abstract
The prevalence of antineutrophil cytoplasmic antibodies (ANCA) was studied in 12 children with Wegener's granulomatosis. The serum samples were taken in the active phase of disease and were screened for ANCA by indirect immunofluorescence with normal neutrophils and enzyme linked immunosorbent assay (ELISA) using crude neutrophil extract, proteinase 3, myeloperoxidase, cathepsin G, lactoferrin, and elastase as antigens. Of these 12 patients, 10 wre positive for ANCA in the active phase of their illness, and they showed a predominantly cytoplasmic ANCA staining pattern on indirect immunofluorescence. There were high titres of ANCA directed against crude neutrophil extract, proteinase 3, myeloperoxidase, and cathepsin G. IgM isotypes occurred as commonly as IgG isotypes. Therefore, screening for ANCA is usually but not invariably positive in children with Wegener's granulomatosis. Specific diagnosis still relies on clinical and pathological features, and the value of ANCA in the diagnosis of paediatric Wegener's granulomatosis requires further study.
Collapse
Affiliation(s)
- S N Wong
- Nephrourology Unit, Ormond Street Hospital for Children NHS Trust, London, UK
| | | | | |
Collapse
|
47
|
O'Devaney K, Ferlito A, Hunter BC, Devaney SL, Rinaldo A. Wegener's granulomatosis of the head and neck. Ann Otol Rhinol Laryngol 1998; 107:439-45. [PMID: 9596226 DOI: 10.1177/000348949810700515] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Among the more puzzling non-neoplastic necrotizing lesions of the head and neck area is Wegener's granulomatosis. This is a condition of unknown cause that may present (in the head and neck area) with ulceration of the nasal septum, sinus mucosa, oral mucosa, or external ear canal, or even destruction of the vocal cord. Diagnosis depends on the pathologic finding of a characteristic inflammatory reaction pattern (which, in its best-developed form, includes necrosis, granulomatous inflammation, and vasculitis) and the serum finding of an elevated antinuclear cytoplasmic antigen. Treatment is principally medical, with the use of powerful immunosuppressive agents. Distinction from other conditions that may mimic Wegener's granulomatosis (such as malignant lymphoma and infections) is of critical importance in constructing an appropriate treatment strategy.
Collapse
Affiliation(s)
- K O'Devaney
- Department of Pathology, University of Michigan, Ann Arbor, USA
| | | | | | | | | |
Collapse
|